ENDRA Life Sciences Inc. NDRA · Stock Open ENDRA Life Sciences Inc. in new tab
ENDRA Life Sciences Inc. Analysis (NDRA)
Is ENDRA Life Sciences Inc. a good investment? ENDRA Life Sciences Inc. (NDRA) is currently trading at 6.31 USD.
In terms of valuation, the stock trades at a P/E ratio of 0.22. This relatively low multiple may signal that ENDRA Life Sciences Inc. is undervalued compared to historical market norms.
Earnings Schedule: ENDRA Life Sciences Inc. is expected to release its next earnings report on Nov. 13, 2026. The market consensus estimate for Forward EPS is -3.04.
Investor FAQ
Does ENDRA Life Sciences Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is ENDRA Life Sciences Inc.?
ENDRA Life Sciences Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 13, 2026. The company currently has a trailing EPS of -6.42.
Company Profile
ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is involved in the development of thermo-acoustic enhanced ultrasound technology that uses pulsed energy source such as radio frequency to transmit energy deep into tissue and generate ultrasonic waves to create high-contrast images for use in the treatment of non-alcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion analysis. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.
| Split Date | Split Ratio to 1 |
|---|---|
| Dec. 9, 2022 | 1:20 |
| Aug. 20, 2024 | 1:50 |
| Nov. 7, 2024 | 0.03 |
Community Discussion